Mercy Hospital Washington
Washington, Missouri, United States
Hospital in Washington, Missouri
901 E Fifth St, Washington, MO 63090
About Mercy Hospital Washington
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
55
Alliance for Clinical Trials in Oncology
24
SWOG Cancer Research Network
20
ECOG-ACRIN Cancer Research Group
15
Wake Forest University Health Sciences
6
NRG Oncology
4
Eastern Cooperative Oncology Group
1
Mercy Research
1
Vertos Medical, Inc.
1
Clinical Trials at Mercy Hospital Washington
During the past decade, Mercy Hospital Washington conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 22 clinical trials were completed, i.e. on
average, 18.6% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 19 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
2011-06-20
2023-12-31
Active, not recruiting
53
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
2013-08-01
2019-09-01
Completed
227
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
2012-08-08
2027-07-19
Active, not recruiting
129
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
2014-01-24
2025-03-20
Recruiting
146
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
2013-12-23
2023-07-01
Active, not recruiting
488
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
2014-02-01
Active, not recruiting
117
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
2014-05-01
2019-12-31
Terminated
37
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mercy Hospital Washington" #1 sponsor was "National Cancer Institute (NCI)" with 55 trials, followed by "Alliance for Clinical Trials in Oncology" with 24 trials
sponsored, "SWOG Cancer Research Network" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Wake Forest University Health Sciences"
with 15 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital Washington"
#1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at Mercy Hospital Washington
According to Clinical.Site data, the most researched conditions in "Mercy Hospital Washington" are
"Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Metastatic Malignant Neoplasm in the Brain" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials) and "Clinical Stage IV Cutaneous Melanoma AJCC v8" (5 trials). Many other conditions were trialed in "Mercy Hospital Washington" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Hospital Washington
Most popular intervention types in "Mercy Hospital Washington" are "Drug" (94 trials), "Other" (66 trials), "Biological" (51 trials), "Procedure" (41 trials) and "Radiation" (9 trials). Other intervention types were less common.
The name of intervention was led by "Biospecimen Collection" (27 trials), "Quality-of-Life Assessment" (26 trials), "Questionnaire Administration" (23 trials), "Computed Tomography" (21 trials) and "Laboratory Biomarker Analysis" (20 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Hospital Washington
The vast majority of trials in "Mercy Hospital Washington" are
111 trials for "All" genders, 13 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Mercy Hospital Washington
Currently, there are NaN active trials in "Mercy Hospital Washington".
undefined are not yet recruiting,
57 are recruiting,
48 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Mercy Hospital Washington,
6 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Hospital Washington, 4 "Phase 1"
clinical trials were conducted, 67 "Phase 2" clinical
trials and 50 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".